featured
Long-Term Survival in HER2+ MBC Treated With First-Line Trastuzumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Survival in HER2-Positive Metastatic Breast Cancer Treated With First-Line Trastuzumab: Results From the French Real-Life Curie Database
Breast Cancer Res Treat 2019 Sep 05;[EPub Ahead of Print], E Kaczmarek, C Saint-Martin, JY Pierga, E Brain, R Rouzier, A Savignoni, E Mouret-Fourme, V Dieras, I Piot, C Dubot, M Carton, F LereboursFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.